Bicycle Therapeutics

Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2009 · IPO 2019

Therapeutics based on its proprietary bicyclic peptide product platform

Revenue $73M

Power Law Unicorn$1–10B valuation tier Colt$25–100M revenue

Knowledge graph

Market map Peptides: The Next Drug Modality Stack Apr 10, 2026

Talent graph

Bicycle Therapeutics's talent

Book a demo to see the people

Employees mapped 271 incl. 8 AI specialists

Founders /100 quality score

Key operators 6 quality /100

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on Bicycle Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Novartis Venture Fund

Series A 4 investors entered at this stage

SV Health Investors

SR One

Atlas Venture

Astellas Venture

Series B+ 11 investors entered at this stage

Fairmount Funds Management

Forbion Capital Partners

Cambridge Innovation Capital

Longwood Fund

University of Cambridge

Vertex Ventures HC

EPFL Swiss Federal Polytechnic School of Lausanne

Deep Track Capital

EcoR1 Capital

Perceptive Advisors

RA Capital Management

Bicycle Therapeutics mafia

Startups founded by Bicycle Therapeutics alumni

Former Bicycle Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

Kymera TherapeuticsEst. 2016

Bruce BoothUnited States

Signal score90

NodTheraEst. 2016

Alan WattUnited Kingdom

Signal score70

Be BioEst. 2020

Lea HachigianUnited States

Signal score63

RAI FinanceEst. 2020

KLKevin LeeSouth Korea

Signal score40

Book a demo to explore the full alumni network →

Global footprint

Where Bicycle Therapeutics has talent and traffic

Workforce by country

5 countries with
team presence

🇬🇧 United Kingdom65%

🇺🇸 United States33.5%

🇮🇹 Italy0.4%

🇪🇸 Spain0.4%

🇦🇺 Australia0.4%

5 countries shown

Web traffic by country

7.8K monthly visits
across markets

🇺🇸 United States51.3%

🇬🇧 United Kingdom20.5%

🇯🇵 Japan16.7%

🇩🇪 Germany7.7%

🇮🇳 India3.8%

Top 5 markets shown

Patent intelligence

$117M patent portfolio · 75 active families

Estimated portfolio value

$117M

3.9× larger than top peer Day One Biopharmaceuticals ($30M)

75 active patent families

Where Bicycle Therapeutics innovates CarcinosisCovalent modifierCyclic peptideDiseaseEffector

Where Bicycle Therapeutics concentrates vs peers

Each axis is a top-10 topic across Bicycle Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Bicycle Therapeutics

An AI-synthesized read of the highest-engagement posts about Bicycle Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bicycle Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles